In young rodents, estradiol increases cell proliferation in the dentate gyrus of the hippocampus. However, it is unknown if the old brain retains this response to estradiol. Here we assessed the generation of new cells in the dentate gyrus of old rats after administration of estradiol or a soy extract, since soy is used as an alternative to hormonal replacement therapy in postmenopausal women. In a first experiment, 12-month-old animals were ovariectomized and studied at 14, 18 or 22 months of age. The production of new cells, assessed by the incorporation of bromodeoxyuridine (BrdU), was similar in 14-and 18-month-old rats. However, there was a significant reduction in the number of BrdU-immunoreactive cells at 22 months of age. In a second experiment, 22-month-old ovariectomized animals were treated for 10 weeks with a weekly s.c. injection of 150 mg estradiol valerianate or with 60 mg/kg per day soy extract added to the drinking water. Both treatments increased significantly the production of new cells in the dentate gyrus. These findings indicate that the brains of old rats retain the ability to increase the production of new cells in response to estradiol and soy extracts. q
Introduction
In agreement with animals studies, estrogen replacement therapy (ERT) has been shown to increase memory and cognitive function in healthy postmenopausal women (Wise, 2003) . However, the Women's Health Initiative (WHI) randomized trial, suggests an increased risk of dementia as a result of long-lasting hormonal treatment with conjugated equine estrogen plus medroxyprogesterone acetate (Shumaker et al., 2003; Yaffe, 2003) . The results of the WHI study emphasize the need for a better understanding on the effects of sex hormones in the aged brain and after a long period of gonadal hormonal deprivation. Furthermore, dietary phytoestrogens, compounds with weak estrogenic or antiestrogenic activity such as the isoflavones contained in soy extracts (Dixon, 2004) , have been proposed as alternatives of HRT (Huntley and Ernst, 2004) . Neuroprotective properties of soy extracts and phytoestrogens have been documented in animal and cellular models (Wang et al., 2001; Gelinas and Martinoli, 2002; Linford and Dorsa, 2002; Zhao et al., 2002; Zeng et al., 2004) . However, it is unknown whether the aged brain is still responsive to the actions of these compounds. In this study, we have assessed cell proliferation in the dentate gyrus of the hippocampus of old rats after estradiol or soy extract treatments. This parameter was selected, since estradiol regulates cell proliferation in this brain area in young female rodents (Tanapat et al., 1999; Banasr et al., 2001; Ormerod and Galea, 2001) . The dentate gyrus is one of the brain areas where neurogenesis is maintained through adult life in rodents. However, cell proliferation in the dentate gyrus dramatically decreases in old age (Kuhn et al., 1996) and it is unknown whether estrogens may affect this aging-associated process. 
Material and methods
Wistar albino female rats from our in house colony (Complutense University) were raised and maintained on 12:12 h light:dark cycle. The animals were fed a normal rat chow (A.04; Panlab, Barcelona, Spain) and had free access to tap water. All procedures used in these experiments followed the European Union normative (86/609/EEC) and were approved by the Institutional Animal Care Committee of the Complutense University.
To reduce circulating sex steroid levels, animals were bilaterally ovariectomized under Equithesin anesthesia (chloral hydrate, pentobarbital, 1,2-propilenglicol, magnesium sulfate; i.p., 3 ml/kg b.w.), when they were 12-months-old. In a first study, to assess the effect of aging on the incorporation of bromodeoxyuridine (BrdU) in the dentate gyrus, ovariectomized animals were killed when they were 14-, 18-or 22-months-old. To determine the effect of estradiol on the number of BrdU-immunoreactive cells, 22-month-old rats that were ovariectomized at 12 months were treated for 10 weeks with a weekly s.c. injection of 150 mg estradiol valerianate (Sigma, St Louis, MO.) or vehicle (100 ml of sunflower seed oil). To determine the effect of soy extract on the incorporation of BrdU, 22-monthold ovariectomized animals were treated for 10 weeks with 60 mg/kg per day soy extract containing 10% of isoflavones (Phytosoya w , Arkochim, Madrid, Spain), added to the drinking water. The amount of drinking water was measured on a daily basis in order to adjust the total amount of soy extract administered. Animals treated with estradiol, soy extract or vehicle were killed at 24 months of age.
All animals received four intraperitoneal injections of 15 mg/ml (50 mg/kg) BrdU (5-bromo-2-deoxyuridine; Sigma, St Louis, MO.) in 0.9% NaCl during the last 3 days. Animals received one injection at 10:00 AM on day 3 before death, one injection at 10:00 AM on day 2 before death and two injections at 10:00 AM and 4:00 PM, respectively, on day 1 before death. Animals were killed 24 h after the last injection of BrdU. Multiple injections of BrdU were chosen to assure that an adequate number of cells were labeled for accurate quantification. The survival time after BrdU administration was selected for the assessment of the number of newly generated cells. Since other tissue samples from these animals were used for additional biochemical experiments that were incompatible with the treatment with fixatives, conventional perfusion of the fixative through the ascending aorta was not possible. Therefore, we used an immersion fixation protocol that has previously shown to result in a good morphological preservation of rat brain samples (Garcia-Ovejero et al., 2001) . The animals were killed by decapitation, the brain was quickly removed, meninges were detached and the right cerebral hemisphere was trimmed in a block containing the whole hippocampus. The tissue blocks were first immersed for 1 h at room temperature in 4% paraformaldehyde in phosphate buffer 0.1 M, pH 7.4 and then maintained in the same fixative solution for 7 days at 4 8C. After fixation, the tissue blocks were transferred to phosphate buffer 0.1 M pH 7.4. For each brain, coronal sections (50 mm thick) of the entire hippocampus of the right cerebral hemisphere were obtained with a Leica Vibratome (Heidelberg, Germany).
Endogenous peroxidase activity was quenched by incubating brain sections, for 30 min at room temperature, in 0.1 M phosphate buffer, with 10% methanol and 3% hydrogen peroxide. To ensure detection of BrdU-labeled nuclei, DNA was denatured by incubating the sections for 15 min at 37 8C in 2 N HCl. After this step, sections were rinsed twice in 0.1 M borate buffer (pH 8.5), followed by a rinse in 0.1 M phosphate buffer, and then incubated for 1 h at room temperature with 0.1 M phosphate buffer, with 0.3% Triton X-100 and 0.3% bovine serum albumin. This buffer solution was used in the following washes and incubations. Sections were then incubated overnight at 4 8C with mouse anti-BrdU antibody (1:5000; mAb G3G4 Developmental Studies Hybridoma Bank, Iowa City, IA). After rinsing in buffer, sections were incubated for 90 min at room temperature in biotinylated goat anti-mouse IgG (1:1000; Pierce, Rockford, IL), rinsed and transferred to the peroxidase avidin biotin complex (1:250; Pierce) for 45 min at room temperature. Peroxidase was detected using diaminobenzidine as chromogen. For double immunofluorescence, the following antibodies were used: rat anti-BrdU (1:2000; Accurate Scientific, Westbury, NY), mouse antibIII tubulin (1:8000, Promega, Madison, WI) and mouse anti-GFAP (1:2000; Sigma, St Louis, MO), as described previously (Perez-Martin et al., 2003) .
The analysis of BrdU-labeled cells was performed on coded sections. BrdU-positive cells were counted on every 6th section (300 mm apart) throughout the entire rostralcaudal extension of the right half of the dentate gyrus (from the rostral extreme of the hippocampus at K1.80 mm from bregma to the caudal end at K6.80 mm from bregma). The same areas were studied for all the animals and all the experimental groups. Fifteen to seventeen sections were analyzed from each animal. All BrdU-positive cells were counted with a 100! microscope objective. Cell counts were restricted to the granular cell layer (GCL) and the subgranular zone (SGZ) of the dentate gyrus. The SGZ was defined as a two-nucleus-wide band below the apparent border between GCL and the hilus. The total number of BrdU-labeled cells was estimated as described previously (Cameron and McKay, 2001 ). Briefly, BrdU-immunoreactive nuclei that came into focus while focusing down through the thickness of the section were counted according to the optical disector principle. BrdU-immunoreactive nuclei located in the uppermost focal plane were ignored. We considered BrdU-positive nuclei those completely filled with diaminobenzidine product or showing patches of variable intensity. The number of BrdU-immunonreactive nuclei counted in the GCL/SGZ was multiplied by 6 (because every 6th section was used) to estimate the total number of BrdU-immunoreactive cells in the dentate gyrus. Data were analyzed using one-way ANOVA followed by the DMS test. The n used for the statistical analysis was the number of animals (indicated in Table 1 ). P values !0.05 were considered statistically significant.
Results
Cells incorporating BrdU were found in the dentate gyrus of all studied animals (Fig. 1) . BrdU-positive nuclei were found in the hilus, in the subgranular zone (SGZ) and in the inner part of the granule cell layer (GCL). BrdU cells in the SGZ/GCL were in most cases present in clusters and were always located at the border between the GCL and the hilus. BrdU-immunoreactive nuclei in this location were of bigger size than BrdU-immunoreactive nuclei in the hilus, which probably correspond to glial cells. GFAP and bIII tubulin did not colocalize with BrdU immunoreactivity (not shown), probably due to the short time of survival after the BrdU administration. The number of BrdU-immunoreactive cells in the GCL and SGZ of the dentate gyrus was drastically affected by aging (Table 1 ). The number of BrdU-immunoreactive cells was similar in 14-and 18-month-old rats. However, a strong decrease in the number of BrdU-immunoreactive cells was observed between 18 and 22 months of age (Table 1) .
Having established that the production of new cells was significantly decreased in 22-month-old rats, animals of this age were chosen to assess the effect of estradiol and soy extract in a second experiment. Animals treated with estradiol showed a significantly higher number of BrdUimmunoreactive cells in the GCL/SGZ than control animals treated with vehicle (Table 1) . Soy extract had a similar effect than estradiol. Animals treated for 10 weeks with soy extract showed a significantly higher number of BrdU-immunoreactive cells in the GCL/SGZ than control animals (Table 1) . It should be noted, however, that neither estradiol nor soy extract were able to increase the number of BrdU-immunoreactive cells in the GCL/SGZ of 24-monthold animals to the levels observed at 18 months of age.
Discussion
Our findings, showing a strong decrease in the number of BrdU-labeled cells in the GCL/SGZ of the dentate gyrus of Wistar rats between 18 and 22 months of age, are in agreement with previous studies reporting a decline with advancing age in hippocampal neurogenesis in rodents (Kuhn et al., 1996) . Estrogen is known to promote hippocampal neurogenesis in young female rats (Tanapat et al., 1999; Banasr et al., 2001; Ormerod and Galea, 2001 ). Our present findings indicate that the hormone also affects the production of new cells in old, long-term ovariectomized rats. In contrast to the human ovary, where the production of sex steroids is interrupted by menopause, the rat ovaries maintain steroidogenic activity after reproductive aging (Lu et al., 1979) . Therefore, rats were ovariectomized to have a long-term depletion of gonadal hormones to mimic the situation after menopause in primates. In our study, the hormonal treatment was initiated at 22 months of age, 10 months after ovariectomy, and the animals were killed when they were 24-months-old. The animals treated with estradiol showed a significantly higher number of BrdU-immunoreactive cells in the GCL/SGZ than control animals. Interestingly, soy extract had a similar effect than estradiol on the number of BrdU cells in the dentate gyrus. Animals treated with soy extract showed a significantly higher number of BrdU-immunoreactive cells than control animals and a similar number of BrdU-labeled cells than animals treated with estradiol. These findings indicate that the aged brain retains the capacity to respond to exogenous estradiol and soy extract by increasing the production of new cells in the hippocampus, even after a long period of hormonal deprivation. It should be noted, however, that in the present study the time of survival after BrdU administration was selected for the assessment of the production of new cells. This short survival time may be the cause why BrdU immunoreactivity was not colocalized with glial or neuronal markers. Therefore, the effects of estradiol and soy extracts on the differentiation and survival of newly generated cells in the dentate gyrus of old animals remain to be determined. Previous studies have shown that phytoestrogens are neuroprotective (Wang et al., 2001; Gelinas and Martinoli, 2002; Linford and Dorsa, 2002; Zhao et al., 2002; Zeng et al., 2004) and increase memory and cognitive function in rats (Lund et al., 2001; Lephart et al., 2002) . However, to our knowledge this is the first demonstration that soy extracts may affect the generation of new cells in the hippocampus. Further studies explore the mechanisms involved in this action of soy extract in the aging brain. A direct effect on estrogen receptors may be postulated, since soy phytoestrogens are able to regulate estrogen receptormediated transcription (Mueller et al., 2004) and since estrogen receptors are involved in hippocampal neurogenesis (Perez-Martin et al., 2003) . However, estrogen receptor-independent mechanisms cannot be excluded.
Although the treatments with estradiol and soy extract significantly increased the production of new cells in the dentate gyrus of old rats, these treatments were unable to recover the rate of production of new cells at younger ages. This suggests that aging-associated decrease in the availability of other factors may limit the impact of estradiol and soy phytoestrogens on neurogenesis. Further studies are therefore necessary to determine the effect of the association of estradiol or soy phytoestrogens with other factors on hippocampal neurogenesis in old animals.
